The lack of inhibition of these pathways by PTEN inactivation is associated with high Gleason score (Koksal et al, 2004) and tumour progression in prostate cancer (Koksal et al, 2004; Bertram et al, 2006). Here, PTEN is linked to prostate carcinoma.